HomeAbout R5 PharmaceuticalsCustomersExperienceServicesNewsContact R5 Pharmaceuticals
login

R5 News

Meet R5 in Paris (CPhI/ICSE) and New Orleans (AAPS)

R5 will be exhibiting at the major pharmaceutical trade shows.

Paris Oct 5 – 7 (CPhi/ICSE) ... Read More

R5 - Management Team of the year finalist.

The British Venture Capital Association National awards final will be held at One Mayfair , London S... Read More

Aesica Pharmaceuticals aquires R5

Aesica Pharmaceuticals has today announced that it has successfully acquired leading research and de... Read More

R5 and Lena Nanoceutics undertake joint commercial development of novel milling technology

R5 Pharmaceuticals Ltd and Lena Nanoceutics Ltd have today agreed to jointly develop the market for ... Read More

You need Adobe Flash Player version 8 or above to view this movie. Click here to download the latest version of Flash Player.

R5 Pharmaceuticals Ltd.

R5 develops and manufactures new medicines and clinical trial materials for Phase 1 and Phase 2 clinical trials. R5 is a subsidiary of Aesica Pharmaceuticals Ltd. Projects include most dosage forms and all are produced at R5's GMP labs.   
           

R5 is licensed by MHRA for the GMP manufacture and testing of Investigational Medical Products (IMPs) and Specials.

Oral

Tablet
Capsule

Sterile

Aseptic
Freeze Dried
Sterilised

Topical

Creams
Ointments

Liquid

Syrups
Gels

Others

Veterinary
Paediatric
Spray Drying
Analytical   Chemistry